| Date Filed | Type | Description |
| 05/25/2023 |
4
| Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 398 shares
@ $11.71, valued at
$4.7k
Sold 1,244 shares
@ $12.3005, valued at
$15.3k
Sold 15 shares
@ $13.005, valued at
$195.1 |
|
| 03/16/2023 |
4
| Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 1,768 shares
@ $18.732, valued at
$33.1k
|
|
| 12/20/2022 |
4
| Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Sold 1,468 shares
@ $18.7746, valued at
$27.6k
Sold 815 shares
@ $19.3595, valued at
$15.8k
Sold 3,801 shares
@ $20, valued at
$76k
|
|
| 11/28/2022 |
4
| Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 353 shares
@ $12.84, valued at
$4.5k
Sold 600 shares
@ $21.3765, valued at
$12.8k
Sold 277 shares
@ $21.9914, valued at
$6.1k
|
|
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2021 |
4
| Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 11/17/2021 |
4
| Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 86 shares
@ $50.99, valued at
$4.4k
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/22/2020 |
4
| Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Exercised 2,750 options to buy
@ $1.39, valued at
$3.8k
|
|
| 11/17/2020 |
4
| Tahir Misbah (CFO) has filed a Form 4 on IGM Biosciences, Inc.|
Txns:
| Granted 42 shares
@ $45.45, valued at
$1.9k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2019 |
3
| Tahir Misbah (CFO) has filed a Form 3 on IGM Biosciences, Inc. |